No impact of first-line systemic therapy on quality of life of patients with metastatic breast cancer? Data from the MaLife-project.

Marschner, N., Tesch, H., Karcher, A., Ammon, A., Nusch, A., Boller, E., Spring, L., Jänicke, M., 2014.

Oncol Res Treat 37 (suppl 5)(V371), 111. doi:10.1159/000368945

Studie: TMK; Indikation: Mammakarzinom; Jahr: 2014; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com